Log in
iScreen™ Oral Fluid Drug Screen Cube uses lateral flow chromatographic immunoassay technology to detect drugs and their metabolites in human oral fluid. The collection swab is placed inside the mouth until the saliva saturation indicator confirms that an adequate specimen has been collected. The swab is then inserted into the testing device, where the oral fluid migrates across individual test membranes containing antibodies specific to each targeted drug.
If the drug concentration is below the established screening cutoff level, both the Control (C) and Test (T) lines appear, indicating a negative result. If the drug concentration is equal to or greater than the cutoff level, only the Control (C) line appears, indicating a preliminary positive result.
Because this device provides only preliminary screening results, any positive finding should be confirmed using Gas Chromatography/Mass Spectrometry (GC-MS), Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS), or another appropriate confirmatory laboratory method before making medical, legal, employment, or insurance decisions
Amphetamine is a prescription central nervous system (CNS) stimulant commonly used to treat Attention Deficit Hyperactivity Disorder (ADHD) and narcolepsy. It works by increasing certain neurotransmitters in the brain, helping improve focus, attention, and alertness. However, amphetamine is also frequently misused because of its stimulating and performance-enhancing effects.
Due to its abuse potential, amphetamine is routinely included in workplace, clinical, forensic, and rehabilitation drug testing programs.
Increased energy
Improved alertness
Elevated mood
Increased heart rate
Reduced appetite
Restlessness
Anxiety
Insomnia
Long-term misuse may result in dependence, cardiovascular complications, aggression, and mental health disorders.
Speed, Uppers, Bennies, Dexies, Pep Pills, Addys.
Amphetamine is generally detectable in oral fluid for approximately 24–48 hours after use
Cocaine is a powerful central nervous system stimulant derived from the coca plant. It produces intense but short-lived feelings of euphoria, increased confidence, and energy by rapidly increasing dopamine levels in the brain. Cocaine has a high potential for abuse and addiction and is routinely included in workplace, clinical, and forensic drug testing panels.
Increased energy
Euphoria
Heightened alertness
Rapid heartbeat
Elevated blood pressure
Reduced appetite
Anxiety
Restlessness
Long-term misuse may contribute to heart attack, stroke, depression, and substance dependence.
Coke, Blow, Snow, Crack, Rock, Flake, Yayo, White, Dust.
Cocaine is generally detectable in oral fluid for approximately 24–48 hours after use
Methamphetamine is a highly addictive synthetic stimulant that affects the brain and central nervous system. It produces intense feelings of euphoria, increased energy, and heightened alertness. Because of its powerful stimulant effects, methamphetamine has a high risk of abuse and long-term addiction.
Intense euphoria
Increased energy
Heightened alertness
Rapid heartbeat
Elevated blood pressure
Reduced appetite
Anxiety
Aggressive behavior
Long-term misuse may result in severe weight loss, hallucinations, paranoia, memory impairment, and permanent brain damage.
Meth, Crystal Meth, Ice, Glass, Tina, Crank.
Methamphetamine is generally detectable in oral fluid for approximately 24–72 hours after use.
Opiates are naturally occurring opioid drugs derived from the opium poppy, including morphine and codeine. They are commonly prescribed to relieve moderate to severe pain but are also frequently abused because of their pain-relieving and euphoric effects.
Repeated misuse can quickly lead to tolerance, physical dependence, addiction, and life-threatening respiratory depression. Because of their widespread misuse, opiates are routinely included in workplace, clinical, rehabilitation, and forensic drug testing panels.
Pain relief
Euphoria
Relaxation
Drowsiness
Constricted pupils
Slowed breathing
Nausea
Constipation
Long-term misuse may result in opioid dependence, overdose, respiratory failure, coma, and death.
Smack, Dope, H, Horse, Junk, Mud, Big O.
Opiates are generally detectable in oral fluid for approximately 24–48 hours after use
Oxycodone is a semi-synthetic opioid analgesic prescribed to treat moderate to severe pain. It is commonly used after surgery, injury, or for chronic pain management. While highly effective when taken as prescribed, oxycodone also has a high potential for misuse because of its pain-relieving and euphoric effects.
Because oxycodone is one of the most commonly misused prescription opioids, many professional drug screening programs include a dedicated test for this drug.
Pain relief
Euphoria
Relaxation
Drowsiness
Slowed breathing
Dizziness
Nausea
Constipation
Long-term misuse may lead to opioid dependence, overdose, respiratory depression, and death.
Oxy, OCs, Percs, Roxies, Hillbilly Heroin.
Oxycodone is generally detectable in oral fluid for approximately 24–48 hours after use
Phencyclidine (PCP), commonly known as Angel Dust, is a dissociative hallucinogenic drug originally developed as a surgical anesthetic. Although its medical use has been discontinued, PCP continues to be abused because of its powerful hallucinogenic and mind-altering effects.
PCP affects the central nervous system and can significantly alter perception, mood, behavior, and coordination. Because of its unpredictable effects and high abuse potential, it remains an important component of workplace, clinical, and forensic drug screening programs.
Hallucinations
Detachment from reality
Confusion
Aggressive behavior
Numbness
Loss of coordination
Elevated blood pressure
Agitation
Angel Dust, Sherm, Wet, Rocket Fuel, Love Boat, Embalming Fluid.
PCP is generally detectable in oral fluid for approximately 24–72 hours after use
The iScreen™ Oral Fluid Drug Screen Cube (6 Panel) is suitable for:
Employment drug testing
Insurance screening programs
Pre-employment testing
Random workplace drug testing
Occupational health clinics
Clinical laboratories
Rehabilitation and addiction treatment centers
Law enforcement agencies
Correctional facilities
Substance abuse monitoring
Professional point-of-care drug testing
The iScreen™ Oral Fluid Drug Screen Cube (6 Panel) provides a fast, reliable, and non-invasive solution for the preliminary detection of six commonly abused drugs using oral fluid. Designed for employment and insurance testing, it features an integrated saliva collection swab with a built-in saturation indicator, helping ensure adequate specimen collection while reducing opportunities for specimen adulteration and tampering.
The device delivers easy-to-read preliminary results in approximately 5 minutes, and the results can be photocopied for convenient documentation and record keeping. As with all rapid immunoassay screening devices, any preliminary positive result should be confirmed using Gas Chromatography/Mass Spectrometry (GC-MS), Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS), or another appropriate confirmatory laboratory method before medical, legal, employment, or insurance decisions are made.
The iScreen™ Oral Fluid Drug Screen Cube is a rapid, non-invasive oral fluid drug screening device designed for employment and insurance testing. Using advanced lateral flow chromatographic immunoassay technology, the device provides fast and convenient qualitative detection of six commonly abused drugs in human oral fluid, with easy-to-read preliminary results available in approximately 5 minutes.
Oral fluid drug screening simplifies the specimen collection process while helping reduce opportunities for specimen substitution, adulteration, and tampering. The integrated saliva collection swab features an easy-to-read saturation indicator, ensuring that a sufficient oral fluid specimen has been collected before testing begins.
The compact, self-contained Cube combines specimen collection and testing into a single device, making it easy to administer in workplace, insurance, occupational health, and professional testing environments. Results can also be photocopied for documentation and record keeping, making the device suitable for routine screening programs.
The iScreen™ Oral Fluid Drug Screen Cube is available in 5 to 10 drug panel configurations, allowing organizations to customize their oral fluid drug testing programs according to their screening requirements. This 6-panel configuration simultaneously screens for Amphetamine (AMP), Cocaine (COC), Methamphetamine (MET), Opiates (OPI), Oxycodone (OXY), and Phencyclidine (PCP) from a single oral fluid specimen.
This assay provides preliminary qualitative screening results only. Any preliminary positive result should be confirmed using Gas Chromatography/Mass Spectrometry (GC-MS), Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS), or another appropriate confirmatory laboratory method before medical, legal, employment, or insurance decisions are made.
The iScreen™ Oral Fluid Drug Screen Cube is intended for in vitro diagnostic use only and is designed specifically for employment and insurance testing
This 6 Panel configuration screens for:
Drug
Typical Oral Fluid Detection Window
Amphetamine (AMP)
24–48 Hours
Cocaine (COC)
24–48 Hours
Methamphetamine (MET)
24–72 Hours
Opiates (OPI)
24–48 Hours
Oxycodone (OXY)
24–48 Hours
Phencyclidine (PCP)
24–72 Hours
A colored line appears in both the Control (C) region and the Test (T) region for each drug panel. Even a faint Test (T) line should be interpreted as a negative result, indicating that the drug concentration is below the established screening cutoff level.
Only one colored line appears in the Control (C) region while no line appears in the corresponding Test (T) region. This indicates that the drug concentration may be at or above the screening cutoff level. Any preliminary positive result should be confirmed using Gas Chromatography/Mass Spectrometry (GC-MS), Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS), or another appropriate confirmatory laboratory method before medical, legal, employment, or insurance decisions are made.
If no colored line appears in the Control (C) region, the test is invalid regardless of whether a Test line appears. Repeat the test using a new device and a fresh oral fluid specimen.
iScreen™ 6 Panel Oral Fluid Drug Screen Cube | Abbott | Amphetamine (AMP) Cocaine (COC) Methamphetamine (MET) Opiates (OPI) Oxycodone (OXY) Phencyclidine (PCP) | ABTOFCUBE0603C 25/Box
Sign up for updates from leading retailers
